Hypertension, possible vascular protection and lercanidipine

References

• Chobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension42, 1206–1252 (2003).
   PubMed Web of Science ®Google Scholar
• European Society of Hypertension–European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertension. J. Hypertens.21, 1011–1052 (2003).
   PubMed Web of Science ®Google Scholar
• Agodoa L, Appel L, Bakris G, on behalf of the African American Study of Kidney Disease and hypertension 9AASK Study Group. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis. JAMA285, 2719–2728 (2001).
   PubMed Web of Science ®Google Scholar
• Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation92, 1326–1331 (1995).
   PubMed Web of Science ®Google Scholar
• Psaty BM, Heckbert SR, Koepsell TD et al. This risk of myocardial infarction associated with antihypertensive drug therapies. JAMA274, 620–625 (1995).
   PubMed Web of Science ®Google Scholar
• Angelico P, Guarneri L, Leonardi A, Testa R. Vascular-selective effect of lercanidipine and other 1,4-dihydropyridines in isolated rabbit tissues. J. Pharm. Pharmacol.51, 709–714 (1995).
   Google Scholar
• Herbette LG, Vecchiarelli M, Sartani A, Leonardi A. Lercanidipine. Short plasma half-life, long duration of action and high cholesterol tolerance. Blood Press.7(Suppl. 2), 10–17 (1998).
   Google Scholar
• Grassi G, Seravalle G, Turri C, Bolla G, Mancia G. Short- versus long-term effects of different dihydropyridines on sympathetic and baroreflex function in hypertension. Hypertension41(3), 558–562 (2003).
   PubMed Web of Science ®Google Scholar
• Fogari R, Mugellini A, Zoppi A et al. Differential effects of lercanidipine and nifedipine GITS on plasma norepinephrine in chronic treatment of hypertension. Am. J. Hypertens.16, 596–599 (2003).
   PubMed Web of Science ®Google Scholar
• Barrios V. Navarro A, Esteras A et al. Antihypertensive efficacy and tolerability of lercanidipine in daily clinical practice. The ELYPSE Study. Eficacia de Lercanidipino y su Perfil de Seguridad. Blood Press.11, 950–100 (2002).
   Google Scholar
• Cafiero M, Giasi M. Long-term (12 month) treatment with lercanidipine in patients with mild to moderate hypertension. J. Cardiovasc. Pharmacol.29(Suppl. 2), S45–S49 (1997).
   PubMedGoogle Scholar
• Marx A, Lichtenthal A, Milbredt C et al. Effect of anthypertensive therapy with a new third generation calcium antagonist lercanidipine on pateints with concomitant diseases. J. Hypertens.22(Suppl. 2), S236 (2004).
   Google Scholar
• Martell N, Lopez-Eady MD, Castro P et al Modifications of the pulse pressure in elderly hypertensives treated with lercanidipine. J. Hypertens.22(Suppl. 2), S121 (2004).
   PubMedGoogle Scholar
• DeGiorgio L, Orlandini F, Malasoma P, Zappa A. Double-blind, crossover study of lercanidipine versus amlodipine in the treatment of mild-to-moderate essential hypertension. Curr. Therapeut. Res.60, 511–520 (1999).
   Web of Science ®Google Scholar
• Cesarone MR, Incandela L, Ledda A et al. Pressure and microcirculatory effects of treatment with lercanidipine in hypertensive patients and in vascular patients with hypertension. Angiology51, S53–S63 (2000).
   PubMed Web of Science ®Google Scholar
• Cleophas TJ, van Ouwerkerk BM, van der Meulen J, Zwinderman AH. Diabetics with hypertension not controlled with ACE inhibitors; alternate therapies. Angiology52, 469–475 (2001).
   PubMed Web of Science ®Google Scholar
• Romito R, Pansini MI, Perticone F, Antonelli G, Pitzalis M, Rizzon P. Comparative effect of lercanidipine, felodipine, and nifedipine GITS on blood pressure and heart rate in patients with mild to moderate arterial hypertension: the Lercanidipine in ADults (LEAD) Study. J. Clin. Hypertens.5, 249–253 (2003).
   PubMedGoogle Scholar
• Leonetti G, Magnani B, Pessina AC et al. Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensives. Am. J. Hypertens.15, 932–940 (2002).
   Google Scholar
• Fogari R, Malmani GD, Zoppi A et al. Comparative effect of lercanidipine and nifedipine gastrointestinal therapeutic system on ankle volume and subcutaneous interstitial pressure in hypertensive patients: a double-blind randomized, parallel-group study. Curr. Ther. Res. Clin. Exp.61, 850–862 (2000).
   Web of Science ®Google Scholar
• Ram CVS. Usefulness of lercanidipine, a new calcium antagonist, for systemic hypertension. Am. J. Cardiol.89, P214 (2002).
   PubMedGoogle Scholar
• Agrawal R, Marx A, Haller H. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension. J. Hypertens.24, 185–192 (2006).
   PubMed Web of Science ®Google Scholar
• Roma J, Sobrino J, Soler-Amigo J et al. Treatment with lercanidipine during six months in hypertensive elderly patients (more than sixty years). J. Hypertens.20(Suppl. 4), S391 (2004).
   Google Scholar
• Ninci MS, Magliocca R, Malliani A. Efficacy and tolerability of lercanidipine in elderly patients with mild to moderate hypertension in a placebo-controlled, double-blind study. J. Cardiovasc. Pharmacol.29, S40–S44 (1997).
   Google Scholar
• Millar-Craig M, Shaffu B, Greenough A et al. Lercanidipine vs lacidipine in isolated systolic hypertension. J. Hum. Hypertens.17, 799–806 (2003).
   PubMed Web of Science ®Google Scholar
• Barbagallo M, Barbagallo Sangiorgi G. Efficacy and tolerability of lercanidipine in monotherapy in elderly patients with isolated systolic hypertension. Aging (Milano)12(5), 375–379 (2000).
   PubMedGoogle Scholar
• Viviani GL, Lercanidipine in type II diabetic patients with mild to moderate arterial hypertension. J. Cardiovasc. Pharmacol.40, 133–139 (2002).
   PubMed Web of Science ®Google Scholar
• Dalla Vestra M, Pozza G, Mosca A et al. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipine. Diabetes Nutr. Metab.17, 259–266 (2004).
   PubMedGoogle Scholar
• Menne J, Park JK, Agrawal R et al. Cellular and molecular mechanisms of tissue protection by lipophilic calcium channel blockers. FASEB J.20, 994–996 (2006).
   PubMed Web of Science ®Google Scholar
• Sarafidis P, Lasaridis A, Hatzistavri L et al. The effect of telmisartan and lercanidipine on blood pressure and insulin resistance in hypertensive patients. Rev. Clin. Pharmacol. Pharmacokinet. Int.18, 60–66 (2004).
   Google Scholar
• Robles NR, Ocon J, Gomez CF et al. Lercanidipine in patients with chronic renal failure: The Zafra study. Ren. Fail.27, 73–80 (2005).
   PubMed Web of Science ®Google Scholar
• Robles NR, Pastor L, Manjon M et al. Lercanidipine in diabetic patients with renal failure. Nefrologia24, 338–343 (2004).
   PubMedGoogle Scholar
• Sabbatini M, Leonardi A, Testa R, Viatoli L, Amenta F. Effect of calcium antagonists on glomerular arterioles in spontaneously hypertensive rats. Hypertension35, 775–779 (2000).
   PubMed Web of Science ®Google Scholar
• Fogari R, Mugelini A, Corradi L et al. Efficacy of lercanidipine vs losartan on left ventricular hypertrophy in hypertensive type 2 diabetic patients (abstr). J. Hypertens.18(Suppl. 2), S63 (2000).
   Google Scholar
• Barrios V, Escobar C, Navarro et al. Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: the LAURA study. Int. J. Clin. Pract.60, 1364–1370 (2006).
   PubMed Web of Science ®Google Scholar
• Borghi C, Prandin MG, Dormi A, Ambrosioni E. Improved tolerability of the dihydropyridine calcium-channel antagonist lercanidipine: the lercanidipine challenge trial. Blood Press.1(Suppl.), 14–21 (2003).
   Google Scholar
• Lund-Johansen P, Stranden E, Helberg S et al. Quantification of leg oedema in postmenopausal hypertensive patients treated with lercanidipine or amlodipine. J. Hypertens.21, 1003–1010 (2003).
   PubMed Web of Science ®Google Scholar
• Pedrinelli R, Dell’omo G, Nuti M, Menegato A, Balbarini A, Mariani M. Heterogeneous effect of calcium antagonists on leg edema: a comparison of amlodipine versus lercanidipine in hypertensive patients. J. Hypertens.21, 1969–1973 (2003).
   PubMed Web of Science ®Google Scholar